.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Teva
US Army
US Department of Justice
Harvard Business School
Express Scripts
Julphar
Fish and Richardson
Colorcon

Generated: December 15, 2017

DrugPatentWatch Database Preview

VOLMAX Drug Profile

« Back to Dashboard

When do Volmax patents expire, and what generic alternatives are available?

Volmax is a drug marketed by Muro and is included in one NDA.

The generic ingredient in VOLMAX is albuterol sulfate. There are thirty-seven drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-002Dec 23, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VOLMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-002Dec 23, 1992► Subscribe► Subscribe
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 1992► Subscribe► Subscribe
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 1992► Subscribe► Subscribe
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 1992► Subscribe► Subscribe
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-002Dec 23, 1992► Subscribe► Subscribe
MuroVOLMAXalbuterol sulfateTABLET, EXTENDED RELEASE;ORAL019604-002Dec 23, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Baxter
Boehringer Ingelheim
AstraZeneca
McKesson
US Army
Dow
Fish and Richardson
Harvard Business School
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot